This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
I like that the authors made sure to note that there were no immediate clinical applications. Yea for not overselling your work!
Then why are they making a press release of it! I really don't understand press releases...
Because at this point it's an interesting discovery. They were just responsible enough to ward of some intrepid journalist from going crazy.
This may aid in prognostics for breast cancer. Many patients tumors are molecularly profiled with a commercial test called Oncotype. It tests everything from BRCA mutations, to her2/neu amplifications/hormone receptor status.
I completely understand why they did this study and I appreciate the implications of the work. My issue is specifically with the fact that it was made into a press release. Why does this have to be publicized?
That was my point too Jane! How do universities decide to release statements about any given research?
I agree, it is an interesting artcile and it was good that they published it. Maybe other research labs can take something out of this finding and make more progress to putting it into clinical trials.
Doctors have used perfect replicas of childrens' hearts to uncover and repair hidden defects
An experiment testing people’s altruism in the face of electric shocks is clear on one thing: we are drawn to these little blasts
Researchers gear up tests in West Africa to see whether blood from Ebola survivors can help people who are sick with the disease. This is part of a broader effort to test therapies in West Africa.
The virus's foray into Europe coincides with peak production of Christmas turkeys, the poultry species most vulnerable to bird flu
A novel kind of nanoparticle could lead to more effective cancer treatments.Patients and doctors often don’t know if surgery to remove cancerous tissue was successful until scans are performed months later. A new kind of nanoparticle could show patients if they’re in the clear much earlier.
One challenge in evaluating the effectiveness of different medical procedures, is that patients behave differently after different procedures. Is this true for patients getting heart surgery?
It is only in the aftermath of treatment that survivors discern that their adrenalin alone wont fuel the rest of their recovery. For many, surviving cancer is followed by even more hardship
Just down the road from Facebook and Google, Dr. Phil Wagner runs a laboratory dedicated to optimizing the performance of some of the world's top athletes. At Sparta Performance Science in Menlo Park, California, Wagner and his team bring the spirit of Silicon Valley to bear on the athletic world, helping athletes find the tiny advantages that add to championships. Join us for a trip inside the lab to see where sports meets science.
Pieter Cohen, an internist in Massachusetts, got interested in dietary supplements several years ago, when some of his …
The risk of overdiagnosis and false positives means the UK may be barking up the wrong tree in trialling a wider target age range for breast screening